📊 CLNN Key Takeaways
Investment Thesis
Clene Inc. exhibits severe financial distress with negative stockholders' equity of -$17.6M, massive operating losses, and critically weak liquidity. The company is burning cash at an unsustainable rate (-$18.6M FCF) with minimal revenue generation ($200K), indicating the business model is not viable in its current state and poses significant financial risk.
CLNN Strengths
- Maintains modest cash position of $5.2M providing short-term runway
- Revenue generation demonstrates some commercial traction despite minimal scale
- High insider activity (25 Form 4 filings) may indicate management confidence or restructuring efforts
CLNN Risks
- Negative stockholders' equity of -$17.6M indicates technical insolvency and shareholder value destruction
- Operating cash burn of -$18.5M annually with only $5.2M cash on hand creates critical liquidity crisis
- Revenue collapsed 41.5% YoY to just $200K while operating losses remain severe at -$23.1M
- Liabilities ($35.7M) exceed assets ($18.1M) by 97%, indicating structural financial failure
- Current ratio of 0.83x shows inability to cover short-term obligations with current assets
- Long-term debt of $17.8M is unsustainable given negative cash generation and minimal revenue
Key Metrics to Watch
- Quarterly cash burn rate and months of runway remaining
- Revenue trajectory and path to profitability viability
- Stockholders' equity recovery through financing or operational improvement
- Operating cash flow inflection point
CLNN Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CLNN Profitability Ratios
CLNN vs Healthcare Sector
How Clene Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CLNN Balance Sheet & Liquidity
CLNN 5-Year Financial Trend
5-Year Trend Summary: Clene Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $-5.67 indicates the company is currently unprofitable.
CLNN Growth Metrics (YoY)
CLNN Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $15.0K | -$751.0K | $-0.85 |
| Q2 2025 | $27.0K | -$751.0K | $-0.78 |
| Q1 2025 | $73.0K | -$751.0K | $-0.09 |
| Q3 2024 | $87.0K | -$2.4M | $-0.38 |
| Q2 2024 | $91.0K | -$6.8M | $-1.06 |
| Q1 2024 | $73.0K | -$11.1M | $-0.09 |
| Q3 2023 | $108.0K | -$2.4M | $-0.02 |
| Q2 2023 | $35.0K | -$4.5M | $-0.07 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CLNN Capital Allocation
CLNN SEC Filings
Access official SEC EDGAR filings for Clene Inc. (CIK: 0001822791)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CLNN
What is the AI rating for CLNN?
Clene Inc. (CLNN) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CLNN's key strengths?
Maintains modest cash position of $5.2M providing short-term runway. Revenue generation demonstrates some commercial traction despite minimal scale.
What are the risks of investing in CLNN?
Negative stockholders' equity of -$17.6M indicates technical insolvency and shareholder value destruction. Operating cash burn of -$18.5M annually with only $5.2M cash on hand creates critical liquidity crisis.
What is CLNN's revenue and growth?
Clene Inc. reported revenue of $200.0K.
Does CLNN pay dividends?
Clene Inc. does not currently pay dividends.
Where can I find CLNN SEC filings?
Official SEC filings for Clene Inc. (CIK: 0001822791) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CLNN's EPS?
Clene Inc. has a diluted EPS of $-0.46.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.